Tobacco, alcohol and vaping
Ask about the actual products and use pattern, then offer practical support. Combustible tobacco, smokeless tobacco, vaping, nicotine pouches and alcohol require accurate distinctions.
Quick revision summary
Identify the exposure before discussing risk
A smoking history should include product, daily or weekly amount, duration and previous quit attempts. Ask separately about cigars, pipes, shisha, smokeless tobacco, betel or areca-containing products, vapes and nicotine pouches.
Explain vaping and nicotine honestly
Vaping is different from burning tobacco and can help adults stop smoking. It should not be described as harmless, particularly for people who do not smoke or for children. Long-term oral evidence remains less mature than for combustible tobacco.
Review support and persistent findings separately
Agree a practical next step: a referral, a planned discussion with a pharmacist or GP, or a patient-selected reduction goal. Document whether the referral was accepted and who will arrange it.
Common mistake
Do not equate vaping with combustible smoking or treat a plausible irritant as proof that a persistent lesion is benign.
Tobacco, alcohol and vaping
Ask about the actual products and use pattern, then offer practical support. Combustible tobacco, smokeless tobacco, vaping, nicotine pouches and alcohol require accurate distinctions.
Identify the exposure before discussing risk
A smoking history should include product, daily or weekly amount, duration and previous quit attempts. Ask separately about cigars, pipes, shisha, smokeless tobacco, betel or areca-containing products, vapes and nicotine pouches. Someone who does not smoke cigarettes may not volunteer other products. Ask what is in a preparation and where it is held rather than assuming its name predicts its composition.
Record current, previous and never-smoking status, with vaping separately described. A person who has completely switched from smoking to vaping should not be recorded as a current smoker merely because they still use nicotine. Dual use matters because continued combustible exposure remains harmful. Update the history without judgement and acknowledge changes the patient has already achieved.
Connect tobacco to oral disease
Smoking increases periodontal risk, can impair healing and affects the prognosis of some dental treatments. It can also suppress visible gingival bleeding, so a relatively quiet gingival appearance does not establish health. Tobacco and alcohol are important oral-cancer exposures, with combined use increasing risk further. Previous exposure remains relevant after cessation, although stopping offers substantial health benefit.
Smokeless tobacco and areca-containing products have particular mucosal and cancer implications. Examine the placement site and the rest of the mouth. Local irritation is a possible explanation for a lesion, but persistence, induration or an unusual red or white change must still be assessed. Removing a product is not a substitute for investigation of a suspicious lesion.
Offer very brief smoking advice
The useful sequence is to ask, advise and act. Establish smoking status, explain that support improves the chance of quitting and offer a concrete referral to an available stop-smoking service. Link the conversation to the patient’s own priorities, such as healing, periodontal stability or keeping teeth, without making treatment a threat or a moral reward.
Discuss the available support route rather than prescribing a cessation regimen from memory. Behavioural support and evidence-based stop-smoking aids can be combined according to current guidance and individual suitability. Ask about the response to previous attempts, including withdrawal and practical triggers. If the patient declines today, leave the offer open and record the conversation without repeatedly lecturing.
Explain vaping and nicotine honestly
Vaping is different from burning tobacco and can help adults stop smoking. It should not be described as harmless, particularly for people who do not smoke or for children. Long-term oral evidence remains less mature than for combustible tobacco. A balanced conversation should not encourage a former smoker to return to cigarettes because the clinician has presented all nicotine products as equally harmful.
Ask about the device, frequency, dual use and oral symptoms. Nicotine pouches are not the same as smokeless tobacco, and products vary. Document their placement and assess associated changes. Where the evidence is uncertain, say so; do not manufacture a numerical cancer risk or attribute every lesion to vaping without examining its clinical features.
| Exposure | Record accurately | Counselling emphasis |
|---|---|---|
| Combustible tobacco | Amount, duration, current and previous use | Offer effective cessation support |
| Vaping | Current use and any continued smoking | Different risk profile; not harmless |
| Smokeless tobacco / areca | Ingredients and placement site | Specific oral risk and specialist support |
| Nicotine pouches | Product, frequency and placement | Assess local changes; avoid unsupported risk estimates |
Take an alcohol history in useful units
Ask about drink type, serving size, strength, frequency and the largest usual drinking occasion. Units are calculated from volume and alcohol strength, so one glass or one can is an unreliable measure. A structured tool such as AUDIT-C can help identify people who would benefit from brief advice or further support. Explain why the question matters to oral and general health.
The UK Chief Medical Officers’ lower-risk advice is not to drink regularly above 14 units a week, spreading consumption over at least three days if drinking that amount. This is lower risk, not risk-free. Pregnancy, medicines, illness and dependence can change advice. Suspected dependence needs an appropriate medical pathway; abrupt unsupervised withdrawal can be dangerous.
Review support and persistent findings separately
Agree a practical next step: a referral, a planned discussion with a pharmacist or GP, or a patient-selected reduction goal. Document whether the referral was accepted and who will arrange it. At the next visit, ask what happened and whether the support was accessible. A failed attempt can identify a new approach rather than demonstrate an inability to change.
Continue lesion surveillance and periodontal care while supporting behaviour change. A persistent ulcer should not be put on hold until the patient quits. Conversely, absence of a lesion today does not make continued tobacco exposure safe. Clear explanations, examination and a contact route for new changes are distinct parts of preventive care.
A distinction to remember
Do not equate vaping with combustible smoking or treat a plausible irritant as proof that a persistent lesion is benign.
A patient has stopped smoking and now vapes. How should the history and advice be recorded?
Reveal the reasoning
Record them as a former smoker or non-current smoker with current vaping, including the previous smoking exposure and any dual use. Recognise the benefit of stopping combustible tobacco, discuss ongoing uncertainties accurately, and support continued smoking cessation without suggesting that vaping is harmless.
Test your recall
Which products should be asked about beyond cigarettes?
Show answer
Ask about cigars, pipes, shisha, smokeless tobacco, betel or areca-containing preparations, vapes and nicotine pouches. Use names familiar to the patient and clarify ingredients. A patient answering no to smoking may still have a clinically relevant oral exposure.
